Combating HIV resistance – focus on darunavir

Darunavir is a second-generation protease inhibitor designed to have antiviral efficacy against HIV-1 isolates harboring multiple resistance mutations to protease inhibitors. Pivotal trials conducted in treatment-experienced HIV-infected individuals have demonstrated significantly greater virologica...

Descripción completa

Detalles Bibliográficos
Autor principal: Tremblay, Cécile L
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621389/
https://www.ncbi.nlm.nih.gov/pubmed/19209258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621389/
https://www.ncbi.nlm.nih.gov/pubmed/19209258

Ejemplares similares